Features Screener Stocks Charts
Sign In Sign Up

Natural Capsule Cash Flow Statement

NSE:NATCAPSUQ | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

9.59x

NATCAPSUQ's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.

Free Cash Flow

₹-178.78M

NATCAPSUQ's free cash flow was negative at ₹-178.78M in FY 2025, up 77.6% from FY 2024. The company spent more on capital investments than it generated from operations.

CapEx Intensity

166.8%

Capital expenditure consumed 166.8% of operating cash flow in FY 2025 for NATCAPSUQ, typical of capital-intensive industries.

2-year NATCAPSUQ cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 80.52M 27.91M
Cash flow Operating Activities -83.54M 267.52M
Investments in PPE -716.28M -446.30M
Cash flow Investing Activities -725.86M -444.85M
Dividend Paid -9.30M 0
Cash flow Financing Activities 817.17M 161.67M
Cash at beginning of period 14.78M 22.55M
Cash at end of period 22.55M 6.89M
Free Cash Flow -799.82M -178.78M

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025